227 related articles for article (PubMed ID: 8995233)
1. IkappaB alpha overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-kappaB activation but not tumor necrosis factor-alpha-induced apoptosis.
Cai Z; Körner M; Tarantino N; Chouaib S
J Biol Chem; 1997 Jan; 272(1):96-101. PubMed ID: 8995233
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells.
Huang Y; Johnson KR; Norris JS; Fan W
Cancer Res; 2000 Aug; 60(16):4426-32. PubMed ID: 10969788
[TBL] [Abstract][Full Text] [Related]
3. Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells.
McDade TP; Perugini RA; Vittimberga FJ; Carrigan RC; Callery MP
J Surg Res; 1999 May; 83(1):56-61. PubMed ID: 10210643
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells through inhibition of nuclear factor-kappaB by an IkappaBalpha "super-repressor".
Muenchen HJ; Lin DL; Walsh MA; Keller ET; Pienta KJ
Clin Cancer Res; 2000 May; 6(5):1969-77. PubMed ID: 10815922
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-kappab-independent and -dependent pathways.
Hall JL; Wang X; Van Adamson ; Zhao Y; Gibbons GH
Circ Res; 2001 Jun; 88(12):1247-53. PubMed ID: 11420300
[TBL] [Abstract][Full Text] [Related]
6. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
[TBL] [Abstract][Full Text] [Related]
8. Fas-associated death-domain protein inhibits TNF-alpha mediated NF-kappaB activation in cardiomyocytes.
Chao W; Shen Y; Li L; Zhao H; Meiler SE; Cook SA; Rosenzweig A
Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2073-80. PubMed ID: 15980038
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor kappaB protects pancreatic beta-cells from tumor necrosis factor-alpha-mediated apoptosis.
Chang I; Kim S; Kim JY; Cho N; Kim YH; Kim HS; Lee MK; Kim KW; Lee MS
Diabetes; 2003 May; 52(5):1169-75. PubMed ID: 12716748
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of TNFalpha cytotoxicity: activation of NF-kappaB and nuclear translocation.
Claudio E; Segade F; Wrobel K; Ramos S; Bravo R; Lazo PS
Exp Cell Res; 1996 Apr; 224(1):63-71. PubMed ID: 8612692
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1.
Manna SK; Zhang HJ; Yan T; Oberley LW; Aggarwal BB
J Biol Chem; 1998 May; 273(21):13245-54. PubMed ID: 9582369
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells.
Dikov MM; Oyama T; Cheng P; Takahashi T; Takahashi K; Sepetavec T; Edwards B; Adachi Y; Nadaf S; Daniel T; Gabrilovich DI; Carbone DP
Cancer Res; 2001 Mar; 61(5):2015-21. PubMed ID: 11280761
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis.
Soares MP; Muniappan A; Kaczmarek E; Koziak K; Wrighton CJ; Steinhäuslin F; Ferran C; Winkler H; Bach FH; Anrather J
J Immunol; 1998 Nov; 161(9):4572-82. PubMed ID: 9794384
[TBL] [Abstract][Full Text] [Related]
14. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis.
Takada Y; Singh S; Aggarwal BB
J Biol Chem; 2004 Apr; 279(15):15096-104. PubMed ID: 14711835
[TBL] [Abstract][Full Text] [Related]
15. Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway.
Sethi G; Ahn KS; Sandur SK; Lin X; Chaturvedi MM; Aggarwal BB
J Biol Chem; 2006 Aug; 281(33):23425-35. PubMed ID: 16785236
[TBL] [Abstract][Full Text] [Related]
16. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
17. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
Roussel RR; Barchowsky A
Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
[TBL] [Abstract][Full Text] [Related]
18. Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IkappaB phosphorylation and NF-kappaB activation.
Alpert D; Schwenger P; Han J; Vilcek J
J Biol Chem; 1999 Aug; 274(32):22176-83. PubMed ID: 10428782
[TBL] [Abstract][Full Text] [Related]
19. L-Buthionine-(S,R)-sulfoximine, an irreversible inhibitor of gamma-glutamylcysteine synthetase, augments LPS-mediated pro-inflammatory cytokine biosynthesis: evidence for the implication of an IkappaB-alpha/NF-kappaB insensitive pathway.
Haddad JJ
Eur Cytokine Netw; 2001; 12(4):614-24. PubMed ID: 11781188
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
